BLU — BELLUS Health Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.87bn
- $1.56bn
- $0.02m
Annual cashflow statement for BELLUS Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.01 | -26 | -31.8 | -71.2 | -76.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.062 | 1.98 | 3.53 | 4.51 | 8.39 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.779 | 2.86 | -1.7 | 5.52 | -9.75 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -7.85 | -21.1 | -29.7 | -61.2 | -77.1 |
| Capital Expenditures | — | 0 | -0.535 | 0 | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -12.3 | -44.6 | 23 | -48.2 | -148 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.3 | -44.6 | 22.5 | -48.2 | -148 |
| Financing Cash Flow Items | -0.004 | -0.053 | -0.071 | -0.457 | -0.43 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 25.6 | 73.1 | 37.3 | 210 | 163 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.54 | 7.74 | 30.2 | 101 | -62.8 |